Synthesis, Urease Inhibition, Antioxidant, Antibacterial, and Molecular Docking Studies of 1,3,4-Oxadiazole Derivatives

Table 2

Antibacterial activity of 1,3,4-oxadiazoles derivatives by micro dilution method (MIC^a values μg/mL).

Compound	E. coli	B. subtilus	S. aureus	S. flexneri
4a	0.313	0.156	1.25	0.313
4b	0.625	0.313	0.156	0.313
4c	2.50	0.156	0.625	0.156
4e	0.156	0.625	0.313	0.313
4f	0.313	0.156	0.156	1.25
4g	0.156	0.625	2.50	0.313
4h	1.25	0.156	0.625	0.156
4i	0.156	0.625	0.313	0.313
4j	0.313	1.25	0.313	0.156
4k	0.156	0.313	0.156	0.156
4l	0.313	2.50	0.625	0.156
4m	0.625	0.156	1.25	0.313
4n	0.625	0.156	0.156	0.156
4o	0.313	0.625	2.50	0.156
4r	1.25	0.313	0.156	0.313
Ciprofloxacin	0.156	0.625	0.156	0.31

^aValues are the average of three reading.